Clinical Trials Directory

Trials / Sponsors / ORIC Pharmaceuticals

ORIC Pharmaceuticals

Industry · 9 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLC
Solid Tumors, EGFR Exon 20 Insertion Mutations, NSCLC
Phase 12025-02-27
CompletedEffect of Food on the Pharmacokinetics of ORIC-114
Food Effect in Healthy Participants
Phase 12023-09-11
RecruitingStudy of ORIC-944 in Patients With Metastatic Prostate Cancer
Metastatic Prostate Cancer
Phase 12022-06-01
RecruitingStudy of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Solid Tumors
Phase 1 / Phase 22022-03-10
CompletedStudy of ORIC-533 in Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Phase 12022-01-06
TerminatedStudy of ORIC-101 in Combination With Enzalutamide
Prostatic Neoplasms
Phase 12019-10-28
TerminatedStudy of ORIC-101 in Combination With Anticancer Therapy
Solid Tumor
Phase 12019-05-02
CompletedSingle and Multiple Dose Study of ORIC-101 in Adult Healthy Subjects
Healthy Volunteers
Phase 12018-03-23
CompletedStudy of ORIC-101 in Healthy Adult Subjects
Healthy Volunteers
Phase 12017-10-19